Open Access
MATEC Web of Conferences
Volume 5, 2013
REMCES XII – XIIe Rencontre Marocaine sur la Chimie de l'État Solide
Article Number 04030
Number of page(s) 3
Section Poster Communications
Published online 09 September 2013
  1. I. Abu Hashim, T. Higashi, T. Anno, K. Motoyama, A. Abd-ElGawad, M. El-Shabouri, T. Borg and H. Arima. Potential use of γ-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin. International Journal of Pharmaceutics 392, 83–91 (2010). [CrossRef]
  2. A. Ahmed, A. Dashevsky and R. Bodmeier. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 75, 375–380 (2010). [CrossRef]
  3. M. Amidi, E. Mastrobattista, W. Jiskoot and W.E. Hennink. Chitosan-based delivery systems for protein therapeutics and antigens. Advanced Drug Delivery Reviews 62, 59–82 (2010). [CrossRef] [PubMed]
  4. G. Crini, P.M. Badot and E. Guibal. Chitine et Chitosane: Du biopolymère à l'application. Presses universitaires de Franche-Comté.
  5. T. Adali and E. Yilmaz. Synthesis, characterization and biocompatibility studies on chitosan-graft-poly (EGDMA). Carbohydrate Polymers 77, 136–141 (2009). [CrossRef]
  6. S.R. Van Tomme, G. Storm and W.E. Hennink. In situ gelling hydrogels for pharmaceutical and biomedical applications. International Journal of Pharmaceutics 355, 1–18 (2008). [CrossRef]
  7. A. Chenite, C. Chaput, D. Wang, C. Combes, M.D. Buschmann, C.D. Hoemann, J.C Leroux, B.L. Atkinson, F. Binette and A. Selmani. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21, 2155–2161 (2000). [CrossRef]
  8. S.A. Agnihotri, N.N. Mallikarjuna, T.M. Aminabhavi. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. Journal of Controlled Release 100, 5–28 (2004). [CrossRef]
  9. S. Kim, S. K. Nishimoto, J. D. Bumgardner, W. O. Haggard, M. W Gaber, Y , Yang. A chitosan/b-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 31, 4157–4166 (2010). [CrossRef]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.